Over 5 years of complete antiandrogen withdrawal response in a patient with prostate cancer: A case report
Progressive prostate cancer is primarily treated with androgen-deprivation therapy. The antiandrogen withdrawal (AAW) response (AAWR) is defined as subjective and/or objective improvement following antiandrogen cessation in patients with elevated prostate-specific antigen (PSA) levels treated with combined androgen blockade (CAB).
